SEC Form D · Amendment · filed January 14, 2021
Immunomic Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Ronald P. Thiboutot · ROCKVILLE, MDDirectorJames W. Wishart · ROCKVILLE, MDDirectorMichael D. Lack · ROCKVILLE, MDDirectorWilliam G. Hearl · ROCKVILLE, MDExec · DirectorC. E. Winzer · ROCKVILLE, MDExec · DirectorJacob Silverman · New York, NYDirectorPatrick Puzzuoli · New York, NYDirectorEdward W. Forman · New York, NYExec · DirectorNoah Gottdiener · New York, NYDirectorNancy Lewis · New York, NYExec · DirectorAlex S. Kim · ROCKVILLE, MDDirectorYang-Gon P. Jin · ROCKVILLE, MDDirectorHyuk Joo P. Jee · ROCKVILLE, MDDirectorArlo P. Mcginn · ROCKVILLE, MDDirectorHanieh Sadathendi · Los Angeles, CAExec · DirectorLeise N. Rosman · Phoenix, AZDirectorKris N. Krane · Phoenix, AZExec · DirectorKarl N. Chowscano · Phoenix, AZDirectorEric A. Naison-Phillips · New York, NYDirectorAlex S. Kim · ROCKVILLE, MDDirectorYang-Gon P. Jin · ROCKVILLE, MDDirectorHyuk Joo P. Jee · ROCKVILLE, MDDirectorArlo P. Mcginn · ROCKVILLE, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗